ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Tightens Monitoring, Upgrades Staff Training In Attempts To Improve Management Of Contracts

January 9, 1981

ASTRO Names Officers; Lane Returns To Rice Univ.

January 5, 2001

CMS To Recognize NCCN’s Drug Compendium.

June 6, 2008

FDA Encourages Study Of Gender Differences

August 6, 1993

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

June 2, 2006

AACR Opposes Human Life Bill; ASCO Backs Cancer Act, Reimbursement

May 8, 1981